Ono Pharmaceutical has bought a seat in a quiet corner of the congested antibody-drug conjugate (ADC) space, agreeing | Ono ...

Booster Therapeutics has launched with $15 million in seed financing and a mission to take on the current crop of targeted ...

Immatics has vaulted into phase 3 on the strength of early-stage data. The biotech is gearing up to start a pivotal trial of ...

Gritstone bio may have left no stone unturned when it came to searching for a financial rescue, but the vaccine biotech has ...

Some six years after picking up Seattle’s Universal Cells for $102 million, Astellas Pharma is opening a second location for ...

Modex’s antibodies contain multiple binding sites and can target several parts of SARS-CoV-2’s spike protein, the tool the ...

Syneos Health has tapped Costa Panagos to take the reins from former CEO Colin Shannon, who will transition to the role of ...

Illumina is welcoming a new addition to its DNA sequencing lineup, with a pair of accessible benchtop instruments that ...

After putting forward preliminary clinical data earlier this year from its neuromodulation implant for reducing chronic ...

A day after the Physics prize was given to two scientists for foundational work on machine learning, the Nobel Prize in ...

Insitro has teamed up with Eli Lilly to help power programs into the clinic, tapping the Big Pharma for an option on ...

InnoCare Pharma’s tyrosine kinase 2 (TYK2) inhibitor has hit the main goals of a phase 2 trial in China, sustaining the ...